			Home About us Contact

Sensory Nerve Action Potential (sensory + nerve_action_potential)

Distribution by Scientific Domains

Medical Sciences	100%

Selected Abstracts

Perineural meperidine blocks nerve conduction in a dose-related manner: a randomized double-blind study

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Issue 6 2009
E. ÖZTÜRK
Background: Meperidine has been shown to exhibit a sensory block in peripheral nerves. However, its motor blockade ability is controversial. The aim of this study was to investigate, electroneurographically, the ability of meperidine to inhibit conduction in both sensory and motor fibres in the ulnar nerve. Materials and methods: The study was conducted in a double-blind, placebo-controlled fashion. Eighteen healthy volunteers were randomized into three groups (Saline, meperidine 1% and meperidine 2%). Three millilitre of the study solution was administered to the ulnar nerve perineurally at the level of the wrist by the guidance of a nerve stimulator. Sensory nerve action potential (SNAP) and compound motor action potential (CMAP) amplitudes were recorded. At least a 20% decrease in the initial response amplitude was accepted as a block. Results: The number of individuals with sensory and motor block with saline, meperidine 1% and meperidine 2% were 0/6, 6/6, 6/6 and 0/6, 5/6, 6/6, respectively (P<0.05). The maximum decrease in the median SNAP and CMAP amplitude values were 4.7% and 8.3% with saline; 38.5% and 46.4% with meperidine 1%; and 100% and 97.8% with meperidine 2%, respectively (P<0.05). Median values for the duration of sensory and motor block with meperidine 1% and meperidine 2% were 45, 52.5 and 30, 32.5 min, respectively. Conclusion: Meperidine blocks sensory and motor nerve conduction in a dose-related manner. [source]

Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy

EUROPEAN JOURNAL OF NEUROLOGY, Issue 7 2010
Y. A. Rajabally
Background:, The presence of electrophysiological demyelination of sensory nerves is not routinely assessed in the evaluation of suspected chronic inflammatory demyelinating polyneuropathy (CIDP). Whether this can be useful is unknown. Methods:, We compared, using surface recording techniques, in 19 patients with typical CIDP and 26 controls with distal large fibre sensory axonal neuropathy, the forearm median sensory conductions, sensory nerve action potential (SNAP) amplitudes and durations and sensory nerve conduction velocities (SNCVs) of median, radial and sural nerves. Results:, Median nerve sensory conduction block (SCB) across the forearm was greater in CIDP patients than in controls (P = 0.005). SNAP durations were longer in CIDP patients for median (P = 0.001) and sural nerves (P = 0.004). Receiver operating characteristic (ROC) curves provided sensitive (>40%) and specific (>95%) cut-offs for median nerve SCB as well as median and sural SNAP durations. SNCVs were significantly slower for median and sural nerves in CIDP patients, but ROC curves did not demonstrate cut-offs with useful sensitivities/specificities. Median SCB or prolonged median SNAP duration or prolonged sural SNAP duration offered a sensitivity of 73.7% for CIDP and specificity of 96.2%. Used as additional parameters, they improved diagnostic sensitivity of the American Academy of Neurology (AAN) criteria for CIDP of 1991, from 42.1% to 78.9% in this population, with preserved specificity of 100%. Discussion:, Sensory electrophysiological demyelination is present and may be diagnostically useful in typical CIDP. SCB detection and SNAP duration prolongation appear to represent more useful markers of demyelination than SNCV reduction. [source]

Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, Issue 4 2005
Eugenia Rota
Abstract This study was aimed at assessing the electrophysiological signs of peripheral neuropathy in diabetes mellitus (DM) type II patients at diagnosis. Nerve conduction studies (NCS) of median, ulnar, peroneal, tibial and sural nerves were performed in 39 newly diagnosed DM subjects and compared to those of 40 healthy controls. Metabolic indices were also investigated. Electrophysiological alterations were found in 32 (82%) of the DM patients, and more than half of them (62.2%) showed multiple (two to five) abnormal parameters. Because most of the subjects (84.4%) had from two to five nerves involved, these alterations were widespread in the seven nerves evaluated. Forty-two percent of the patients had NCS alterations suggestive of distal median mononeuropathy, implying that metabolic factors in DM make the median nerve more susceptible to focal entrapment. A reduced sensory nerve action potential (SNAP) amplitude was observed in the median nerve in 70% of the patients, in the ulnar in 69% and in the sural nerve only in 22%. In the presence of a decrease in the SNAP amplitude of the ulnar or median nerve, the SNAP amplitude of the sural nerve was normal in 82 or 80% of the subjects, respectively. This finding may be in keeping with a distal involvement of the sensory fibres, as explored by routine median or ulnar NCS. No correlation was found between metabolic indices and NCS parameters. In conclusion, a high percentage of newly diagnosed DM patients show signs of neuropathy, and upper limb nerve sensory NCS seem to be more sensitive in detecting it than lower limb NCS. [source]

Effect of size and pressure of surface recording electrodes on amplitude of sensory nerve action potentials

MUSCLE AND NERVE, Issue 2 2004
Antoon A. Ven MSc
Abstract The influence of electrode size on sensory nerve action potential (SNAP) amplitude of the lateral antebrachial cutaneous nerve (LACN) and sural nerve (SN) was studied in 63 healthy volunteers. The SNAP amplitudes were measured using surface recording electrodes of three different sizes, positioned across the nerve. Mean amplitudes using a 5-mm electrode were 9.0% (SN) and 15.3% (LACN) higher than with a 20-mm electrode and 19.4% (SN) and 25.8% (LACN) higher than using a 40-mm electrode. To study the influence of pressure on surface recording electrodes, studies were performed on the LACN in 31 healthy volunteers. Light pressure of the recording electrodes on the skin gave lower amplitudes (15.3%) than did greater pressure or pressure applied between active and reference electrodes. These studies demonstrate that standardized surface recording electrode size and pressure are imperative for obtaining valid and reliable results in experimental studies or in clinical follow-up of patients undergoing nerve conduction studies. Muscle Nerve 30: 234,238, 2004 [source]

Diabetes mellitus exacerbates motor and sensory impairment in CMT1A

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, Issue 4 2008
Soham Sheth
Abstract Charcot-Marie-Tooth disease type 1A (CMT1A) is caused by a duplication of PMP22 on chromosome 17 and is the most commonly inherited demyelinating neuropathy. Diabetes frequently causes predominantly sensory neuropathy. Whether diabetes exacerbates CMT1A is unknown. We identified 10 patients with CMT1A and diabetes and compared their impairment with 48 age-matched control patients with CMT1A alone. Comparisons were made with the Charcot-Marie-Tooth disease (CMT) neuropathy score (CMTNS) and by electrophysiology. The CMTNS was significantly higher in patients with diabetes (20.25 ± 2.35) compared with controls (15.19 ± 0.69; p = 0.01). Values were particularly higher for motor signs and symptoms. Seven of the 10 diabetic patients had CMTNS >20 (severe CMT), while only 7 of the 48 age-matched controls had scores >20. There was a trend for CMT1A patients with diabetes to have low compound muscle action potentials and sensory nerve action potentials, although nerve conduction velocities were not slower in diabetic patients compared with controls. Diabetes was associated with more severe motor and sensory impairment in patients with CMT1A. [source]